download
print

Corporate Governance

Alnylam employees, officers, and directors are held to high standards set by our Board of Directors.
These standards and procedures can be found in the following guidelines.

Governance Guidelines

container-970 d-flex flex-1
Corporate Governance Guidelines - Alnylam Pharmaceuticals

Corporate Governance Guidelines

Download ›
Code of Business Conduct and Ethics - Alnylam Pharmaceuticals

Code of Business Conduct
and Ethics

Download ›
Comprehensive Compliance Program - Alnylam Pharmaceuticals

Comprehensive
Compliance Program

Download ›

Charters

Type View/Download
Nominating and Corporate Governance Committee Charter pdf
Compensation Committee Charter pdf
Audit Committee Charter pdf
Science and Technology Committee Charter pdf

Management Board

We have passionate leaders from the biopharmaceutical industry who bring together their experiences
of drug discovery, drug development, and commercialization.

John Maraganore, PhD

Chief Executive Officer

Barry Greene

President

Jeff Poulton

Chief Financial Officer

Yvonne Greenstreet, MBChB, MBA

Chief Operating Officer

Pushkal Garg, MD

Chief Medical Officer

Laurie Keating, JD

EVP, Chief Legal Officer and Secretary

Saraswathy V. Nochur, PhD

SVP, Chief Regulatory Officer

Akshay Vaishnaw, MD, PhD

President, Research & Development

Kelley Boucher

Chief Human Resource Officer

Read Their Bios Here ›

Board of Directors

We have a team of accomplished leaders from various backgrounds who elevate our initiatives and strategies.

Chair of the Board: Michael W. Bonney

Audit Committee

Michael W. Bonney
Marsha H. Fanucci, Chair
Colleen Reitan

Created to assist the Board of Directors’ oversight of the Company’s accounting and financial reporting processes and the audits of the Company’s financial statements.

Compensation Committee

Steven M. Paul, M.D.
Paul R. Schimmel, Ph.D.
Amy W. Schulman, Chair

Designed to assist the Board of Directors in the discharge of its responsibilities relating to compensation of the Company’s executive officers.

Nominating and Corporate Governance Committee

Dennis A. Ausiello, M.D.
Michael W. Bonney
Marsha H. Fanucci
David E.I. Pyott, Chair
Amy W. Schulman

Recommends to the Board the persons to be nominated for election as directors at any meeting of stockholders; develop and recommend to the Board a set of corporate governance principles applicable to the Company; and oversee the evaluation of the Board.

Science and Technology Committee

Dennis A. Ausiello, M.D.
Steven M. Paul, M.D.
Paul R. Schimmel, Ph.D.
Phillip A. Sharp, Ph.D., Chair

Assists the Board’s oversight of the Company’s research and development activities and to advise the Board with respect to strategic and tactical scientific issues.

Read Their Bios Here ›

Looking for specific information that isn't listed above?

Contact: investors@alnylam.com